Platelet-rich plasma (PRP) therapy has become one of the most widely discussed treatment options in sports medicine over the past two decades. You may have heard about professional athletes using it to recover from tendon injuries or plantar fasciitis. But what does the research actually show, and is it right for you? This article offers a balanced, evidence-based overview.
What Is PRP and How Is It Prepared?
PRP is derived from your own blood. A blood draw of typically 15 to 60 milliliters is taken and processed in a centrifuge, which separates blood components by density. The result is a concentrated layer of plasma containing a much higher concentration of platelets than whole blood; typically 3 to 8 times the baseline platelet count, depending on the preparation system.
Platelets are best known for clotting, but they also carry a range of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-beta), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF). These proteins play roles in tissue repair, angiogenesis (new blood vessel formation), and cell proliferation. The hypothesis behind PRP is that injecting this concentrated solution into an injured tendon, ligament, or joint will amplify the natural healing response in areas where blood supply is limited, like tendons.
What the Research Shows
The evidence base for PRP is growing but remains mixed depending on the injury type. It is important to read this research carefully rather than accepting either enthusiastic endorsement or blanket dismissal.
Lateral Epicondyle Tendinopathy (Tennis Elbow)
This is one of the most studied applications of PRP. A meta-analysis published in the American Journal of Sports Medicine found that PRP injection produced statistically significant improvements in pain and function at 6 and 12 months compared to corticosteroid injection, and that corticosteroid showed better short-term results but worse long-term outcomes. The overall quality of evidence is moderate, and results vary across studies, partly because PRP preparation protocols differ widely between research groups.
Patellar Tendinopathy
For jumper’s knee (patellar tendinopathy), PRP has shown promise in multiple studies but evidence remains limited by small sample sizes and inconsistent preparation protocols. Some trials show significant reductions in pain and functional improvement at 6 to 12 months; others show no significant advantage over dry needling or eccentric exercise programs alone. Eccentric loading protocols remain the first-line evidence-based treatment; PRP may be considered when conservative management has not produced adequate results.
Plantar Fasciitis
PRP for chronic plantar fasciitis has been studied in multiple randomized controlled trials. A review in the British Journal of Sports Medicine noted that PRP outperformed corticosteroid injection at medium and long-term follow-up but that the advantage over comprehensive conservative care is less clear. PRP is generally considered when first-line treatments (stretching, orthoses, physical therapy, and activity modification) have been tried for at least 3 to 6 months without adequate relief.
What to Expect During Treatment
The procedure itself is relatively brief, typically 30 to 60 minutes including blood draw, centrifuge processing, and the injection itself. Ultrasound guidance is used to confirm accurate needle placement in most clinical settings. The injection site is often locally anesthetized to improve comfort.
Post-injection, a temporary increase in pain and swelling is common for 24 to 72 hours as the growth factor cascade activates. Most clinicians recommend avoiding anti-inflammatory medications (NSAIDs and corticosteroids) in the days surrounding the procedure, as these may blunt the intended inflammatory-repair response. Activity is typically restricted for 1 to 2 weeks, followed by a structured rehabilitation program.
Recovery Timeline
PRP is not an immediate fix. Most patients do not notice meaningful improvement until 4 to 8 weeks post-injection, with peak benefit typically seen at 3 to 6 months. A single injection is common, though some protocols call for 2 to 3 injections spaced 2 to 4 weeks apart depending on the condition and initial response.
Who Is a Good Candidate?
PRP is generally considered for athletes who have chronic tendinopathy or ligament issues that have not responded adequately to a full course of conservative treatment (physical therapy, activity modification, and appropriate loading protocols). It is not typically a first-line treatment. Ideal candidates have structural integrity at the injury site (no complete tears), no active infection, and no contraindications such as active anticoagulant therapy, anemia, or platelet dysfunction.
It is worth noting that PRP is not covered by most insurance plans and is considered an elective procedure. Costs vary but typically range from a few hundred to over one thousand dollars per injection. A sports medicine provider can assess whether the evidence supports PRP for your specific injury and circumstances.
The Bottom Line
PRP therapy has a legitimate evidence base for select tendinopathies, particularly lateral epicondyle tendinopathy, with a generally favorable safety profile given its autologous (from your own body) nature. The evidence is less definitive for other conditions. It should be considered part of a comprehensive treatment plan that includes structured rehabilitation, not a replacement for it. As research continues to standardize preparation protocols and improve trial design, the picture will become clearer.
Ready to optimize your performance? Start here or contact our team.